Skip to Content

RDY 612 (Pramipexole Dihydrochloride Extended-Release 0.75 mg)

Pill with imprint RDY 612 is White, Round and has been identified as Pramipexole Dihydrochloride Extended-Release 0.75 mg. It is supplied by Dr. Reddy's Laboratories Limited.

Pramipexole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 0.75 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RDY 612

Pramipexole dihydrochloride extended-release 0.75 mg RDY 612 Front
Pramipexole dihydrochloride extended-release 0.75 mg RDY 612 Back

Pramipexole Dihydrochloride Extended-Release

RDY 612
0.75 mg
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Dr. Reddy's Laboratories Limited
National Drug Code (NDC)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.